Thank you, Mr. Chair. Thank you to the witnesses for appearing.
Mr. McBane, I have a quick question. I'm viewing health care as services and products. I want to take the product side out, the pharmaceuticals, because we've had representation come before committee, whether it be from generics or research based.
Is the service part in jeopardy? Are there any services that are going to be more costly? I'm talking about services in terms of medical staffing, nurses, doctors, and specialists.